{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:24Z","timestamp":1781643504170,"version":"3.54.5"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cellimm.2020.104147","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T02:14:09Z","timestamp":1592014449000},"page":"104147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease"],"prefix":"10.1016","volume":"354","author":[{"given":"Mark","family":"Mellett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2020.104147_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.2012.01110.x","article-title":"Regulation of NF-kappaB by the CARD proteins","volume":"246","author":"Jiang","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2020.104147_b0010","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3389\/fimmu.2018.01136","article-title":"Ancient origin of the CARD-coiled coil\/Bcl10\/MALT1-like paracaspase signaling complex indicates unknown critical functions","volume":"9","author":"Staal","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2148-10-93","article-title":"Evolution of the MAGUK protein gene family in premetazoan lineages","volume":"10","author":"de Mendoza","year":"2010","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0020","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jcp.24543","article-title":"The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders","volume":"229","author":"Scudiero","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellimm.2020.104147_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-5793(01)02414-0","article-title":"Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation","volume":"496","author":"Gaide","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellimm.2020.104147_b0030","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1074\/jbc.M010512200","article-title":"CARD11 and CARD14 are novel caspase recruitment domain (CARD)\/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B","volume":"276","author":"Bertin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0035","doi-asserted-by":"crossref","first-page":"30589","DOI":"10.1074\/jbc.M103824200","article-title":"Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction","volume":"276","author":"McAllister-Lucas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature04926","article-title":"Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity","volume":"442","author":"Gross","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104147_b0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ni1466","article-title":"The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors","volume":"8","author":"Hara","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0050","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni830","article-title":"CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation","volume":"3","author":"Gaide","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0055","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1093\/emboj\/cdf505","article-title":"CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex","volume":"21","author":"Pomerantz","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.cellimm.2020.104147_b0060","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ni824","article-title":"A requirement for CARMA1 in TCR-induced NF-kappa B activation","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/cr.2010.182","article-title":"NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins","volume":"21","author":"Blonska","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.cellimm.2020.104147_b0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2164-14-632","article-title":"An expression atlas of human primary cells: inference of gene function from coexpression networks","volume":"14","author":"Mabbott","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cellimm.2020.104147_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2018.03.1503","article-title":"A CARD10-dependent tonic signalosome activates MALT1 paracaspase and regulates IL-17\/TNF-alpha driven keratinocyte inflammation","author":"Israel","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111255","article-title":"CARD14 expression in dermal endothelial cells in psoriasis","volume":"9","author":"Harden","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2020.104147_b0090","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0095","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/jcp.22667","article-title":"Alternative splicing of CARMA2\/CARD14 transcripts generates protein variants with differential effect on NF-kappaB activation and endoplasmic reticulum stress-induced cell death","volume":"226","author":"Scudiero","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellimm.2020.104147_b0100","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1073\/pnas.1721967115","article-title":"Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome","volume":"115","author":"David","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cellimm.2020.104147_b0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/MCB.00850-12","article-title":"A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival","volume":"33","author":"Chan","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0110","doi-asserted-by":"crossref","first-page":"21405","DOI":"10.1074\/jbc.M102488200","article-title":"Card10 is a novel caspase recruitment domain\/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-811X-8-8","article-title":"PDZ domains and their binding partners: structure, specificity, and modification","volume":"8","author":"Lee","year":"2010","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.cellimm.2020.104147_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.275.5296.73","article-title":"Recognition of unique carboxyl-terminal motifs by distinct PDZ domains","volume":"275","author":"Songyang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2020.104147_b0125","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/jcs.114.7.1253","article-title":"SH3 domains: complexity in moderation","volume":"114","author":"Mayer","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellimm.2020.104147_b0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.sbi.2017.08.006","article-title":"Mechanisms of MAGUK-mediated cellular junctional complex organization","volume":"48","author":"Ye","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0135","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1074\/jbc.M210165200","article-title":"Functional analysis of the nucleotide binding domain of membrane-associated guanylate kinases","volume":"278","author":"Olsen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0140","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1074\/jbc.M115.683714","article-title":"Cooperative control of caspase recruitment domain-containing protein 11 (CARD11) signaling by an unusual array of redundant repressive elements","volume":"291","author":"Jattani","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0145","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1074\/jbc.M116.717322","article-title":"Intramolecular interactions and regulation of cofactor binding by the four repressive elements in the caspase recruitment domain-containing protein 11 (CARD11) inhibitory domain","volume":"291","author":"Jattani","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0150","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3389\/fimmu.2018.02105","article-title":"Mechanisms of regulated and dysregulated CARD11 signaling in adaptive immunity and disease","volume":"9","author":"Bedsaul","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0155","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/ncomms6555","article-title":"Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-kappaB signalling","volume":"6","author":"Hara","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2020.104147_b0160","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1038\/s41467-019-10953-z","article-title":"Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation","volume":"10","author":"Holliday","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2020.104147_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.06.047","article-title":"Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11)","volume":"141","author":"Dadi","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.02.012","article-title":"Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency","volume":"131","author":"Greil","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.11.050","article-title":"Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects","volume":"131","author":"Stepensky","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaci.2013.04.047","article-title":"A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency","volume":"132","author":"Jabara","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0185","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jaci.2013.10.045","article-title":"Combined immunodeficiency associated with homozygous MALT1 mutations","volume":"133","author":"McKinnon","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0190","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1172\/JCI77493","article-title":"Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity","volume":"124","author":"Torres","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2020.104147_b0195","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jaci.2019.03.009","article-title":"Germline CBM-opathies: from immunodeficiency to atopy","volume":"143","author":"Lu","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0200","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0205","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0210","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2020.104147_b0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","article-title":"Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types","volume":"96","author":"Willis","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104147_b0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/8767","article-title":"Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)","volume":"22","author":"Zhang","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0225","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1007\/s13277-014-1791-6","article-title":"CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion","volume":"35","author":"Du","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13277-013-1018-2","article-title":"CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line","volume":"35","author":"Feng","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0235","article-title":"Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2020.104147_b0240","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2012.07.152","article-title":"CARMA3 is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression","volume":"425","author":"Miao","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2020.104147_b0245","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s13277-013-0917-6","article-title":"Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma","volume":"34","author":"Wu","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0250","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1007\/s13277-014-2070-2","article-title":"Overexpression of CARMA3 is associated with advanced tumor stage, cell cycle progression, and cisplatin resistance in human epithelial ovarian cancer","volume":"35","author":"Xie","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0255","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s13277-013-0869-x","article-title":"CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells","volume":"34","author":"Zhao","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0260","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3389\/fimmu.2018.01887","article-title":"CARMA3 is a critical mediator of G protein-coupled receptor and receptor tyrosine kinase-driven solid tumor pathogenesis","volume":"9","author":"McAuley","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0265","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0270","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3389\/fimmu.2018.01836","article-title":"Human CARD9: a critical molecule of fungal immune surveillance","volume":"9","author":"Drummond","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0275","doi-asserted-by":"crossref","unstructured":"F. Lanternier, S.A. Mahdaviani, E. Barbati, H. Chaussade, Y. Koumar, R. Levy, B. Denis, A.S. Brunel, S. Martin, M. Loop, J. Peeters, A. de Selys, J. Vanclaire, C. Vermylen, M.C. Nassogne, O. Chatzis, L. Liu, M. Migaud, V. Pedergnana, G. Desoubeaux, G. Jouvion, F. Chretien, I.A. Darazam, A.A. Schaffer, M.G. Netea, J.J. De Bruycker, L. Bernard, J. Reynes, N. Amazrine, L. Abel, D. Van der Linden, T. Harrison, C. Picard, O. Lortholary, D. Mansouri, J.L. Casanova, A. Puel, Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both, J. Allergy Clin. Immunol., 135 (2015) 1558-1568 e1552.","DOI":"10.1016\/j.jaci.2014.12.1930"},{"key":"10.1016\/j.cellimm.2020.104147_b0280","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89890","article-title":"Extrapulmonary Aspergillus infection in patients with CARD9 deficiency","volume":"1","author":"Rieber","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellimm.2020.104147_b0285","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0290","doi-asserted-by":"crossref","unstructured":"D.M. Evans, C.C. Spencer, J.J. Pointon, Z. Su, D. Harvey, G. Kochan, U. Oppermann, A. Dilthey, M. Pirinen, M.A. Stone, L. Appleton, L. Moutsianas, S. Leslie, T. Wordsworth, T.J. Kenna, T. Karaderi, G.P. Thomas, M.M. Ward, M.H. Weisman, C. Farrar, L.A. Bradbury, P. Danoy, R.D. Inman, W. Maksymowych, D. Gladman, P. Rahman, C. Spondyloarthritis Research Consortium of, A. Morgan, H. Marzo-Ortega, P. Bowness, K. Gaffney, J.S. Gaston, M. Smith, J. Bruges-Armas, A.R. Couto, R. Sorrentino, F. Paladini, M.A. Ferreira, H. Xu, Y. Liu, L. Jiang, C. Lopez-Larrea, R. Diaz-Pena, A. Lopez-Vazquez, T. Zayats, G. Band, C. Bellenguez, H. Blackburn, J.M. Blackwell, E. Bramon, S.J. Bumpstead, J.P. Casas, A. Corvin, N. Craddock, P. Deloukas, S. Dronov, A. Duncanson, S. Edkins, C. Freeman, M. Gillman, E. Gray, R. Gwilliam, N. Hammond, S.E. Hunt, J. Jankowski, A. Jayakumar, C. Langford, J. Liddle, H.S. Markus, C.G. Mathew, O.T. McCann, M.I. McCarthy, C.N. Palmer, L. Peltonen, R. Plomin, S.C. Potter, A. Rautanen, R. Ravindrarajah, M. Ricketts, N. Samani, S.J. Sawcer, A. Strange, R.C. Trembath, A.C. Viswanathan, M. Waller, P. Weston, P. Whittaker, S. Widaa, N.W. Wood, G. McVean, J.D. Reveille, B.P. Wordsworth, M.A. Brown, P. Donnelly, C. Australo-Anglo-American Spondyloarthritis, C. Wellcome Trust Case Control, Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility, Nat. Genet., 43 (2011) 761\u2013767.","DOI":"10.1038\/ng.873"},{"key":"10.1016\/j.cellimm.2020.104147_b0295","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2020.104147_b0300","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis\u2013epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1086\/377159","article-title":"The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs","volume":"73","author":"C. International Psoriasis Genetics","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0310","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1038\/ncomms5331","article-title":"Sequencing-based approach identified three new susceptibility loci for psoriasis","volume":"5","author":"Sheng","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2020.104147_b0315","doi-asserted-by":"crossref","unstructured":"L.C. Tsoi, S.L. Spain, J. Knight, E. Ellinghaus, P.E. Stuart, F. Capon, J. Ding, Y. Li, T. Tejasvi, J.E. Gudjonsson, H.M. Kang, M.H. Allen, R. McManus, G. Novelli, L. Samuelsson, J. Schalkwijk, M. Stahle, A.D. Burden, C.H. Smith, M.J. Cork, X. Estivill, A.M. Bowcock, G.G. Krueger, W. Weger, J. Worthington, R. Tazi-Ahnini, F.O. Nestle, A. Hayday, P. Hoffmann, J. Winkelmann, C. Wijmenga, C. Langford, S. Edkins, R. Andrews, H. Blackburn, A. Strange, G. Band, R.D. Pearson, D. Vukcevic, C.C. Spencer, P. Deloukas, U. Mrowietz, S. Schreiber, S. Weidinger, S. Koks, K. Kingo, T. Esko, A. Metspalu, H.W. Lim, J.J. Voorhees, M. Weichenthal, H.E. Wichmann, V. Chandran, C.F. Rosen, P. Rahman, D.D. Gladman, C.E. Griffiths, A. Reis, J. Kere, P. Collaborative Association Study of, C. Genetic Analysis of Psoriasis, E. Psoriasis Association Genetics, C. Wellcome Trust Case Control, R.P. Nair, A. Franke, J.N. Barker, G.R. Abecasis, J.T. Elder, R.C. Trembath, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nat. Genet., 44 (2012) 1341\u20131348.","DOI":"10.1038\/ng.2467"},{"key":"10.1016\/j.cellimm.2020.104147_b0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmg.2004.018564","article-title":"Mapping of psoriasis to 17q terminus","volume":"42","author":"Hwu","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0325","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0330","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.8178173","article-title":"Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q","volume":"264","author":"Tomfohrde","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2020.104147_b0335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2006.07675.x","article-title":"A classification of psoriasis vulgaris according to phenotype","volume":"156","author":"Griffiths","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0340","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0345","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","article-title":"IL-17 and IL-22: siblings, not twins","volume":"31","author":"Eyerich","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0350","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/eji.200939687","article-title":"The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis","volume":"39","author":"Wolk","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0355","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104147_b0360","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0365","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jaad.2011.11.935","article-title":"Association between pediatric psoriasis and the metabolic syndrome","volume":"66","author":"Au","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2020.104147_b0375","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cellimm.2020.104147_b0380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0385","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","article-title":"Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases","volume":"80","author":"Baker","year":"1968","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0390","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archderm.1991.01680080075005","article-title":"Generalized pustular psoriasis. A review of 63 cases","volume":"127","author":"Zelickson","year":"1991","journal-title":"Arch. Dermatol."},{"issue":"Suppl 1","key":"10.1016\/j.cellimm.2020.104147_b0395","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00403-002-0371-6","article-title":"Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity","volume":"295","author":"Umezawa","year":"2003","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cellimm.2020.104147_b0400","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.16232","article-title":"Pustular psoriasis and related pustular skin diseases","volume":"178","author":"Bachelez","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0405","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0410","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0415","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist","volume":"133","author":"Sugiura","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0420","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellimm.2020.104147_b0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-019-0336-3","article-title":"Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab","volume":"17","author":"Signa","year":"2019","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.cellimm.2020.104147_b0430","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3389\/fimmu.2018.02239","article-title":"Clinical and genetic heterogeneity of CARD14 mutations in psoriatic skin disease","volume":"9","author":"Israel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0435","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/jid.2015.288","article-title":"Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris","volume":"135","author":"Berki","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0440","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15442","article-title":"Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation","author":"Takeichi","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0445","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/bjd.14158","article-title":"CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts","volume":"174","author":"Ammar","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0450","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths","year":"1980","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0455","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00000372-198608000-00001","article-title":"Histologic criteria for the diagnosis of pityriasis rubra pilaris","volume":"8","author":"Soeprono","year":"1986","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.cellimm.2020.104147_b0460","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/jdv.14761","article-title":"Pityriasis rubra pilaris: algorithms for diagnosis and treatment","volume":"32","author":"Roenneberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cellimm.2020.104147_b0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11530070-000000000-00000","article-title":"Pityriasis rubra pilaris: a review of diagnosis and treatment","volume":"11","author":"Klein","year":"2010","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0470","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamadermatol.2016.3601","article-title":"Pityriasis rubra pilaris type V as an autoinflammatory disease by CARD14 mutations","volume":"153","author":"Takeichi","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0475","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2230.1995.tb01368.x","article-title":"Pityriasis rubra pilaris as the initial manifestation of internal neoplasia","volume":"20","author":"Sanchez-Regana","year":"1995","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0480","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000246088","article-title":"Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma","volume":"194","author":"Sharma","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.cellimm.2020.104147_b0485","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-0960.2004.00061.x","article-title":"Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma","volume":"45","author":"Kurzydlo","year":"2004","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0490","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2230.2005.01781.x","article-title":"Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma?","volume":"30","author":"Batchelor","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0495","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1111\/j.1365-2230.2009.03701.x","article-title":"Pityriasis rubra pilaris in association with laryngeal carcinoma","volume":"34","author":"Batinac","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0500","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/1529-0131(199909)42:9<1998::AID-ANR28>3.0.CO;2-D","article-title":"The relationship between pityriasis rubra pilaris and inflammatory arthritis: case report and response of the arthritis to anti-tumor necrosis factor immunotherapy","volume":"42","author":"Conaghan","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2020.104147_b0505","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3476(76)80266-1","article-title":"Hypothyroidism and pityriasis rubra pilaris. Response to thyroid hormone","volume":"88","author":"Tunnessen","year":"1976","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cellimm.2020.104147_b0510","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1067\/mjd.2002.124619","article-title":"Pityriasis rubra pilaris in children","volume":"47","author":"Allison","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0515","first-page":"271","article-title":"Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection","volume":"143","author":"Betto","year":"2008","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"10.1016\/j.cellimm.2020.104147_b0520","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000240018","article-title":"Pityriasis rubra pilaris with preceding cytomegalovirus infection","volume":"219","author":"Kawara","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.cellimm.2020.104147_b0525","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1525-1470.2002.00236_5.x","article-title":"Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two new cases","volume":"19","author":"Mohrenschlager","year":"2002","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/000155599750010517","article-title":"Pityriasis rubra pilaris: a retrospective analysis of 43 patients","volume":"79","author":"Sorensen","year":"1999","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.cellimm.2020.104147_b0535","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1525-1470.2001.01967.x","article-title":"Acute juvenile pityriasis rubra pilaris: a superantigen mediated disease?","volume":"18","author":"Betlloch","year":"2001","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0540","first-page":"639","article-title":"Lymphocyte response to superantigen in a patient with childhood-onset pityriasis rubra pilaris","volume":"38","author":"Yamamoto","year":"1999","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0545","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.1995.tb06939.x","article-title":"Pityriasis rubra pilaris and human immunodeficiency virus infection","volume":"133","author":"Miralles","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0550","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.1999.02829.x","article-title":"HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy","volume":"140","author":"Gonzalez-Lopez","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.02.034","article-title":"CARD14-associated papulosquamous eruption: a spectrum including features of psoriasis and pityriasis rubra pilaris","author":"Craiglow","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0560","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2020.104147_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0570","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","article-title":"The multifunctional role of filaggrin in allergic skin disease","volume":"131","author":"McAleer","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0575","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11882-014-0433-9","article-title":"Skin barrier defects in atopic dermatitis","volume":"14","author":"Agrawal","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.cellimm.2020.104147_b0580","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0585","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00281-015-0544-y","article-title":"The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments","volume":"38","author":"Skabytska","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cellimm.2020.104147_b0590","article-title":"The role of filaggrin in atopic dermatitis and allergic disease","author":"Drislane","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0595","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nri1181","article-title":"The regulation of immunoglobulin E class-switch recombination","volume":"3","author":"Geha","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0600","article-title":"Loss-of-function mutations in CARD14 are associated with a severe variant of atopic dermatitis","author":"Peled","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0605","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0610","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/jid.2015.186","article-title":"Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-Function Mutations in IL36RN in european patients","volume":"135","author":"Mossner","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0615","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bjd.15867","article-title":"The genetic basis for most patients with pustular skin disease remains elusive","volume":"178","author":"Mossner","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0620","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/abd1806-4841.20164016","article-title":"Variants of CARD14 gene and psoriasis vulgaris in southern Chinese cohort","volume":"91","author":"Zhu","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0625","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/jid.2014.46","article-title":"CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort","volume":"134","author":"Sugiura","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0630","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1111\/1346-8138.14608","article-title":"Terbinafine-induced generalized pustular psoriasis in a patient carrying CARD14 mutation","volume":"46","author":"Sakai","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0635","article-title":"Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation","author":"Podlipnik","year":"2017","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0640","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2340\/00015555-2446","article-title":"Target-sequence capture and high throughput sequencing identify a De novo CARD14 mutation in an infant with erythrodermic pityriasis rubra pilaris","volume":"96","author":"Has","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.cellimm.2020.104147_b0645","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/1346-8138.13008","article-title":"CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis","volume":"43","author":"Inoue","year":"2016","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0650","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3389\/fimmu.2018.01564","article-title":"Nuclear factor kappaB activation in a type V pityriasis rubra pilaris patient harboring multiple CARD14 variants","volume":"9","author":"Danis","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0655","doi-asserted-by":"crossref","DOI":"10.1042\/BCJ20160270","article-title":"Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-kappaB activation","author":"Howes","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellimm.2020.104147_b0660","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15252\/embr.201642109","article-title":"The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes","volume":"17","author":"Afonina","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cellimm.2020.104147_b0665","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jid.2018.03.1525","article-title":"CARD14 Gain-of-function mutation alone is sufficient to drive IL-23\/IL-17-mediated psoriasiform skin inflammation in vivo","volume":"138","author":"Mellett","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0670","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bjd.14461","article-title":"Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis","volume":"175","author":"Coto-Segura","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0675","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bjd.12952","article-title":"Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14","volume":"171","author":"Eytan","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0680","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjd.15462","article-title":"Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14","volume":"178","author":"Lwin","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0685","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-018-0087-2","article-title":"CARD-BCL-10-MALT1 signalling in protective and pathological immunity","volume":"19","author":"Ruland","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0690","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1158\/0008-5472.CAN-10-3626","article-title":"CARMA3 is crucial for EGFR-Induced activation of NF-kappaB and tumor progression","volume":"71","author":"Jiang","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2020.104147_b0695","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1101\/gad.1502507","article-title":"CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation","volume":"21","author":"Grabiner","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellimm.2020.104147_b0700","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1073\/pnas.0601947103","article-title":"CARMA3\/Bcl10\/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells","volume":"104","author":"McAllister-Lucas","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cellimm.2020.104147_b0705","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.celrep.2016.02.031","article-title":"CARMA3 is a host factor regulating the balance of inflammatory and antiviral responses against viral infection","volume":"14","author":"Jiang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2020.104147_b0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116062","article-title":"The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-kappaB activation","volume":"9","author":"D'Andrea","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2020.104147_b0715","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jid.2015.12.027","article-title":"MALT1 protease activity controls the expression of inflammatory genes in keratinocytes upon zymosan stimulation","volume":"136","author":"Schmitt","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0720","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.51","article-title":"CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship","volume":"8","author":"Scudiero","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2020.104147_b0725","doi-asserted-by":"crossref","unstructured":"M. Wang, S. Zhang, G. Zheng, J. Huang, Z. Songyang, X. Zhao, X. Lin, Gain-of-function mutation of Card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A, Immunity, 49 (2018) 66-79 e65.","DOI":"10.1016\/j.immuni.2018.05.012"},{"key":"10.1016\/j.cellimm.2020.104147_b0730","article-title":"CARD14\/CARMA2sh and TANK differentially regulate poly(I:C)-induced inflammatory reaction in keratinocytes","author":"Voccola","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellimm.2020.104147_b0735","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.immuni.2005.10.007","article-title":"Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation","volume":"23","author":"Matsumoto","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104147_b0740","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2005.09.014","article-title":"Phosphorylation of the CARMA1 linker controls NF-kappaB activation","volume":"23","author":"Sommer","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104147_b0745","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1084\/jem.20070379","article-title":"IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells","volume":"204","author":"Shinohara","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0750","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.0307858100","article-title":"Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation","volume":"101","author":"Schaefer","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cellimm.2020.104147_b0755","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2014.01.011","article-title":"Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR\/CD28-mediated NF-kappaB induction and cytokine production","volume":"59","author":"Cheng","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0760","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1128\/MCB.02469-05","article-title":"Ca2+\/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation","volume":"26","author":"Ishiguro","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0765","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1074\/jbc.RA119.009551","article-title":"Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling","volume":"294","author":"Wang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0770","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/sj.onc.1210746","article-title":"Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells","volume":"27","author":"Mahanivong","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2020.104147_b0775","doi-asserted-by":"crossref","unstructured":"J. Staal, Y. Driege, M. Haegman, M. Kreike, S. Iliaki, D. Vanneste, I. Affonina, H. Braun, R. Beyaert, Defining the relevant combinatorial space of the PKC\/CARD-CC signal transduction nodes, (2019) 228767.","DOI":"10.1111\/febs.15522"},{"key":"10.1016\/j.cellimm.2020.104147_b0780","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2011.11.015","article-title":"Syk kinase-coupled C-type lectin receptors engage protein kinase C-sigma to elicit Card9 adaptor-mediated innate immunity","volume":"36","author":"Strasser","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104147_b0785","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.celrep.2016.11.018","article-title":"Vav proteins are key regulators of Card9 signaling for innate antifungal immunity","volume":"17","author":"Roth","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2020.104147_b0790","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","article-title":"Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway","volume":"276","author":"Lucas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0795","doi-asserted-by":"crossref","first-page":"32419","DOI":"10.1074\/jbc.M800670200","article-title":"Multiple protein domains mediate interaction between Bcl10 and MALT1","volume":"283","author":"Langel","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0800","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2006.05.027","article-title":"Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation","volume":"23","author":"Wegener","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellimm.2020.104147_b0805","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.molcel.2013.08.032","article-title":"Structural architecture of the CARMA1\/Bcl10\/MALT1 signalosome: nucleation-induced filamentous assembly","volume":"51","author":"Qiao","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellimm.2020.104147_b0810","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1172\/JCI25641","article-title":"cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas","volume":"116","author":"Hu","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2020.104147_b0815","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccell.2016.03.006","article-title":"Targeting non-proteolytic protein ubiquitination for the treatment of diffuse large B cell lymphoma","volume":"29","author":"Yang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellimm.2020.104147_b0820","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1073\/pnas.0712313105","article-title":"NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation","volume":"105","author":"Wu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cellimm.2020.104147_b0825","doi-asserted-by":"crossref","first-page":"25921","DOI":"10.1074\/jbc.M116.754028","article-title":"Molecular determinants of scaffold-induced linear ubiquitinylation of B cell lymphoma\/leukemia 10 (Bcl10) during T cell receptor and oncogenic caspase recruitment domain-containing protein 11 (CARD11) signaling","volume":"291","author":"Yang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104147_b0830","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2013-05-504019","article-title":"A catalytic-independent role for the LUBAC in NF-kappaB activation upon antigen receptor engagement and in lymphoma cells","volume":"123","author":"Dubois","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2020.104147_b0835","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","article-title":"The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes","volume":"14","author":"Sun","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellimm.2020.104147_b0840","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2006.11.008","article-title":"The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway","volume":"26","author":"Blonska","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104147_b0845","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072051","article-title":"Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface","volume":"8","author":"Cabalzar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2020.104147_b0850","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BJ20120035","article-title":"Mechanism and specificity of the human paracaspase MALT1","volume":"443","author":"Hachmann","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellimm.2020.104147_b0855","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni.2540","article-title":"The protease activity of the paracaspase MALT1 is controlled by monoubiquitination","volume":"14","author":"Pelzer","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0860","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0865","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cellimm.2020.104147_b0870","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/emboj.2011.85","article-title":"T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1","volume":"30","author":"Staal","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.cellimm.2020.104147_b0875","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","article-title":"Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation","volume":"153","author":"Uehata","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104147_b0880","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ni.3008","article-title":"Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation","volume":"15","author":"Jeltsch","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0885","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103774","article-title":"MALT1 auto-proteolysis is essential for NF-kappaB-dependent gene transcription in activated lymphocytes","volume":"9","author":"Baens","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2020.104147_b0895","doi-asserted-by":"crossref","first-page":"17847","DOI":"10.1073\/pnas.0904078106","article-title":"Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1","volume":"106","author":"Kojo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cellimm.2020.104147_b0900","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/MCB.01505-07","article-title":"T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b","volume":"28","author":"Qiao","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0905","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.4134","article-title":"Inhibition of CBLB protects from lethal Candida albicans sepsis","volume":"22","author":"Wirnsberger","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0910","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1128\/MCB.24.9.3860-3873.2004","article-title":"Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling","volume":"24","author":"Scharschmidt","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0915","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/MCB.00876-15","article-title":"Negative regulation of CARD11 signaling and lymphoma cell survival by the E3 ubiquitin ligase RNF181","volume":"36","author":"Pedersen","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b0920","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4161\/cc.5.13.2866","article-title":"CIAP2 inhibits anigen receptor signaling by targeting Bcl10 for degredation","volume":"5","author":"Hu","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cellimm.2020.104147_b0925","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1038\/ncomms9777","article-title":"The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-kappaB signalling","volume":"6","author":"Klein","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2020.104147_b0930","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1242\/jcs.185025","article-title":"The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling","volume":"129","author":"Douanne","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellimm.2020.104147_b0935","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122581","article-title":"The E3 ubiquitin ligase RNF7 negatively regulates CARD14\/CARMA2sh signaling","volume":"18","author":"Telesio","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2020.104147_b0940","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2012.04.008","article-title":"Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-kappaB","volume":"36","author":"Paul","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104147_b0945","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.chom.2012.01.019","article-title":"The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity","volume":"11","author":"Yang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cellimm.2020.104147_b0950","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4049\/jimmunol.1700995","article-title":"Essential role of CARD14 in murine experimental psoriasis","volume":"200","author":"Tanaka","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0955","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2020.104147_b0960","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2020.104147_b0965","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0970","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2015.65","article-title":"Analysis of CARD14 polymorphisms in pityriasis rubra pilaris: activation of NF-kappaB","author":"Li","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2020.104147_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104286","article-title":"Gain of function p. E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity","volume":"110","author":"Sundberg","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cellimm.2020.104147_b0980","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949237","article-title":"MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice","author":"Van Nuffel","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cellimm.2020.104147_b0985","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.3389\/fimmu.2019.02330","article-title":"MALT1-deficient mice develop atopic-like dermatitis upon aging","volume":"10","author":"Demeyer","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b0990","doi-asserted-by":"crossref","unstructured":"J.A. Altin, L. Tian, A. Liston, E.M. Bertram, C.C. Goodnow, M.C. Cook, Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3-positive regulatory versus T(H)2 effector cells to cause allergy, J. Allergy Clin. Immunol., 127 (2011) 1277-1285 e1275.","DOI":"10.1016\/j.jaci.2010.12.1081"},{"key":"10.1016\/j.cellimm.2020.104147_b0995","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/imcb.12268","article-title":"CARD11 is dispensable for homeostatic responses and suppressive activity of peripherally induced FOXP3(+) regulatory T cells","volume":"97","author":"Policheni","year":"2019","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cellimm.2020.104147_b1000","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10875-014-0125-1","article-title":"Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation","volume":"35","author":"Punwani","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104147_b1005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MOH.0000000000000257","article-title":"Role of the CARMA1\/BCL10\/MALT1 complex in lymphoid malignancies","volume":"23","author":"Juilland","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cellimm.2020.104147_b1010","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fimmu.2018.01927","article-title":"Holding all the CARDs: how MALT1 controls CARMA\/CARD-dependent signaling","volume":"9","author":"Juilland","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:22:02Z","timestamp":1762107722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874920303075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":202,"alternative-id":["S0008874920303075"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104147","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104147"}}